• “ONE Lab” enables Sai Life Sciences to build a comprehensive digital platform for research and development, and chemistry, manufacturing and controls laboratories, addressing common project implementation challenges.
• Goals include reducing errors, saving time, promoting sustainability, and establishing a unified source of truth for multi-stakeholder collaboration across the research to-development to-commercial manufacturing spectrum.

HYDERABAD — OCTOBER 5, 2023 (GPN): Dassault Systèmes (Euronext Paris: FR0014003TT8, DSY.PA) today announced that Sai Life Sciences, India’s fastest growing contract research, development, and manufacturing organization has selected Dassault Systèmes’ solutions to enhance productivity, elevate data quality, and foster collaboration within Sai Life Sciences Research and Process Development laboratories leading to accelerated drug discovery.

Sai Life Sciences is using Dassault Systèmes’ industry solution experience “ONE Lab” based on the 3DEXPERIENCE platform. The solution, which leverages BIOVIA applications, helps optimise productivity, ensure data accuracy and data security, and enable seamless data accessibility and analysis.

Sai Life Sciences has implemented “ONE Lab” to bolster security measures, and facilitate effortless data access and analysis.  Utilizing “ONE Lab,” Sai Life Sciences is creating an integrated digital platform for its research and development (R&D) and chemistry, manufacturing and controls (CMC) laboratories, effectively tackling some of the most notable challenges ailing the research in this sector, specifically associated with project implementation.

The primary objectives of this selection encompass error reduction, time-saving, the promotion of sustainability practices, and the establishment of a unified, reliable source of information to facilitate multi-stakeholder collaboration spanning research, development and commercial manufacturing.

“With Sai Life Sciences, we are attempting to build a brighter future for life sciences and health care research and development in the country. Our long-term vision is to redefine industry standards by combining transformative technology with unwavering commitment. This is not just about optimizing productivity and data quality; it is about setting a new benchmark for collaboration and efficiency in the industry. We are not simply innovating; we are shaping the future of research, one breakthrough at a time,” said Deepak NG, Managing Director India, Dassault Systèmes.

“With Dassault Systèmes’ solutions, we are ushering in a new era of research and development excellence. The integration of Dassault Systèmes’ ‘ONE Lab’ empowers us to drive productivity, enhance data quality, and fortify data security, revolutionizing our approach to research across the entire spectrum from early-stage development to commercial manufacturing,” said Dr. Damodharen, Chief Quality Officer, Sai Life Sciences.

“ONE Lab” has played a pivotal role in empowering Sai Life Sciences to construct an all-encompassing digital platform for its R&D and CMC laboratories. This accomplishment involved surmounting common project implementation challenges, notably in the realm of change management.

“ONE Lab” offers numerous benefits to the industry, including optimization of laboratories and knowledge utilization for accelerated time-to-market. Furthermore, it contributes to a substantial reduction in compliance risk through the standardization of processes and enhanced data quality. Additionally, the solution delivers a remarkable boost in productivity and efficiency through streamlined processes and automation, leading to a reduction in cycle time, thereby enabling real-time project tracking and expediting decision-making.Ends